Innovation in the dry-eye space has taken off over the last few decades, and now ophthalmologists have more options than ever before for treating patients’ dry-eye disease. “It’s an amazing time to be a specialist in this area because there are so many different therapeutic options available to handle the complexity and variety of the ocular surface issues we encounter on a day-to-day basis in the clinic,” says Christopher Starr, MD, FACS, a cornea and cataract/refractive specialist at Weill Cornell Medicine in New York. “As new treatments get FDA approved and become available, I try to incorporate them into my personal algorithm.” While it’s an exciting time, the plethora of options might feel overwhelming. What’s the best way to incorporate all these into your practice? Read More